Advanced in Disseminated Intravascular Coagulation

Yue M. Han

188 Shizi Street, 
Suzhou, CN 
Advanced in Disseminated Intravascular Coagulation
188 Shizi Street, 
Suzhou, CN 
OverviewLocationsClinical Research

Overview

Yue Han practices in Suzhou, China. Han is rated as an Advanced expert by MediFind in the treatment of Disseminated Intravascular Coagulation. Their top areas of expertise are Thrombocytopenia, Leukemia, Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.

Their clinical research consists of co-authoring 230 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Disseminated Intravascular Coagulation.

Locations

188 Shizi Street, Suzhou, 215006, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

CD19-targeting Chimeric Antigen Receptor T-cell Therapy for Patients with Refractory and Relapsed B-cell Acute Lymphoblastic Leukemia
CD19-targeting Chimeric Antigen Receptor T-cell Therapy for Patients with Refractory and Relapsed B-cell Acute Lymphoblastic Leukemia
Enrollment Status: Active_not_recruiting
Publish Date: October 24, 2024
Intervention Type: Biological
Study Drug: CD19-Positive CAR-T Cells
Study Phase: Phase 1/Phase 2
A Prospective Study of Patients With Isolated Thrombocytopenia Following Hematopoietic Stem Cell Transplantation
A Prospective Study of Patients With Isolated Thrombocytopenia Following Hematopoietic Stem Cell Transplantation
Enrollment Status: Completed
Publish Date: May 06, 2020
Intervention Type: Other, Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

230 Total Publications

Efficacy of venetoclax combined with hypomethylating agents in the treatment of patients newly diagnosed with core binding factor acute myeloid leukemia
Efficacy of venetoclax combined with hypomethylating agents in the treatment of patients newly diagnosed with core binding factor acute myeloid leukemia
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Han's expertise for a condition
ConditionClose
    View All 16 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile